3-bromo-2-methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine, 95.0%, 1g

2-(P-tolyl)butanoic acid, 95%, 10g

2-(1H-Benzoimidazol-2-yl)ethylamine dihydrochloride, 95.0%, 25g

4-Bromo-5-methyl-1-phenyl-1H-indazole, 97%, 1g

(4R,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-4-methyl-1,3-oxazolidin-2-one, 98%, 100mg

1-(4-Methyl-benzyl)-1H-pyrazole-4-carboxylic acid, 95.0%, 1g

6-Amino-2,2-dimethyl-2H-pyrido[3,2-b] [1,4]oxazin-3[4H]-one, 95.0%, 5g

2-AMINO-4-BROMO-6-FLUOROBENZOIC ACID, 95.0%, 100mg

7-(prop-2-yn-1-yl)-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]thiazol-6(7H)-imine hydrobromide, 95.0%, 250mg

(R)-4-Phenyl-2-(2-((S)-p-tolylsulfinyl)phenyl)-4,5-dihydrooxazole, 98%, 100mg

Storage box Work2Store for reaction vials and cryogenic vials, 1 Piece

(1-Isopentyl-1H-pyrazol-5-yl)boronic acid, 95.0%, 250mg

[(5S)-5-amino-5-carboxypentyl](diazyn-1-ium-1-yl)azanide hydrochloride, 95%, 10mg